TOKYO -- SoftBank Group will launch a Japan-focused medical service using artificial intelligence to analyze personal medical data, including genes, through a joint venture with U.S. health care company Tempus AI, Nikkei has learned.
Artificial intelligence
SoftBank Group to launch AI service analyzing medical data
Tech group to team up with U.S. health care company on Japan-based venture
SoftBank Group President and Chairman Masayoshi Son is set to explain further details of the AI medical data joint venture this week. (Photo from SoftBank homepage)
Read Next
Latest on Artificial intelligence
